[{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"
IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14672,"experimentAnswers.text":"NA","experimentAnswers.answerId":null,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":1,"experimentAnswers.question.id":1,"experimentAnswers.question.text":"Cell density","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":null,"experimentAnswers.question.type":"STRING","experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":null,"experimentAnswers.question.answers.text":null,"experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":null,"experimentAnswers.answer.id":null,"experimentAnswers.answer.text":null,"experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":null},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14663,"experimentAnswers.text":"200 µL","experimentAnswers.answerId":null,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":23,"experimentAnswers.question.id":23,"experimentAnswers.question.text":"Secondary enzyme activity incubation volume","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":null,"experimentAnswers.question.type":"STRING","experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":null,"experimentAnswers.question.answers.text":null,"experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":null,"experimentAnswers.answer.id":null,"experimentAnswers.answer.text":null,"experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":null},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14670,"experimentAnswers.text":"1010191","experimentAnswers.answerId":null,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":4,"experimentAnswers.question.id":4,"experimentAnswers.question.text":"Test system lot number","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":null,"experimentAnswers.question.type":"STRING","experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":null,"experimentAnswers.question.answers.text":null,"experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":null,"experimentAnswers.answer.id":null,"experimentAnswers.answer.text":null,"experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":null},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14668,"experimentAnswers.text":"10 min","experimentAnswers.answerId":null,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":6,"experimentAnswers.question.id":6,"experimentAnswers.question.text":"Incubation time","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":null,"experimentAnswers.question.type":"STRING","experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":null,"experimentAnswers.question.answers.text":null,"experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":null,"experimentAnswers.answer.id":null,"experimentAnswers.answer.text":null,"experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":null},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14662,"experimentAnswers.text":"10 min","experimentAnswers.answerId":null,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":24,"experimentAnswers.question.id":24,"experimentAnswers.question.text":"Secondary enzyme activity incubation time","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":null,"experimentAnswers.question.type":"STRING","experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":null,"experimentAnswers.question.answers.text":null,"experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":null,"experimentAnswers.answer.id":null,"experimentAnswers.answer.text":null,"experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":null},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14669,"experimentAnswers.text":"200 µL","experimentAnswers.answerId":null,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":5,"experimentAnswers.question.id":5,"experimentAnswers.question.text":"Incubation volume","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":null,"experimentAnswers.question.type":"STRING","experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":null,"experimentAnswers.question.answers.text":null,"experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":null,"experimentAnswers.answer.id":null,"experimentAnswers.answer.text":null,"experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":null},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14664,"experimentAnswers.text":"30 min","experimentAnswers.answerId":null,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":21,"experimentAnswers.question.id":21,"experimentAnswers.question.text":"Precipitant pre-incubation time","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":null,"experimentAnswers.question.type":"STRING","experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":null,"experimentAnswers.question.answers.text":null,"experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":null,"experimentAnswers.answer.id":null,"experimentAnswers.answer.text":null,"experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":null},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14666,"experimentAnswers.text":"0.015 - 100 µM","experimentAnswers.answerId":null,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":15,"experimentAnswers.question.id":15,"experimentAnswers.question.text":"Precipitant concentrations tested","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":null,"experimentAnswers.question.type":"STRING","experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":null,"experimentAnswers.question.answers.text":null,"experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":null,"experimentAnswers.answer.id":null,"experimentAnswers.answer.text":null,"experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":null},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14671,"experimentAnswers.text":"0.05 mg/mL","experimentAnswers.answerId":null,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":2,"experimentAnswers.question.id":2,"experimentAnswers.question.text":"Protein concentration","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":null,"experimentAnswers.question.type":"STRING","experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":null,"experimentAnswers.question.answers.text":null,"experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":null,"experimentAnswers.answer.id":null,"experimentAnswers.answer.text":null,"experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":null},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14667,"experimentAnswers.text":"4 µM","experimentAnswers.answerId":null,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":11,"experimentAnswers.question.id":11,"experimentAnswers.question.text":"Object concentrations tested","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":null,"experimentAnswers.question.type":"STRING","experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":null,"experimentAnswers.question.answers.text":null,"experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":null,"experimentAnswers.answer.id":null,"experimentAnswers.answer.text":null,"experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":null},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14661,"experimentAnswers.text":"No dilution","experimentAnswers.answerId":null,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":25,"experimentAnswers.question.id":25,"experimentAnswers.question.text":"Dilution factor","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":null,"experimentAnswers.question.type":"STRING","experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":null,"experimentAnswers.question.answers.text":null,"experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":null,"experimentAnswers.answer.id":null,"experimentAnswers.answer.text":null,"experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":null},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14665,"experimentAnswers.text":"250 µL","experimentAnswers.answerId":null,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":20,"experimentAnswers.question.id":20,"experimentAnswers.question.text":"Precipitant pre-incubation volume","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":null,"experimentAnswers.question.type":"STRING","experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":null,"experimentAnswers.question.answers.text":null,"experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":null,"experimentAnswers.answer.id":null,"experimentAnswers.answer.text":null,"experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":null},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14673,"experimentAnswers.text":null,"experimentAnswers.answerId":24,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":22,"experimentAnswers.question.id":22,"experimentAnswers.question.text":"Precipitant pre-incubation condition","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":1,"experimentAnswers.question.type":null,"experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":26,"experimentAnswers.question.answers.text":"No NADPH with no precipitant","experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":22,"experimentAnswers.answer.id":24,"experimentAnswers.answer.text":"NADPH with no precipitant","experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":22},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14673,"experimentAnswers.text":null,"experimentAnswers.answerId":24,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":22,"experimentAnswers.question.id":22,"experimentAnswers.question.text":"Precipitant pre-incubation condition","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":1,"experimentAnswers.question.type":null,"experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":25,"experimentAnswers.question.answers.text":"No NADPH with precipitant","experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":22,"experimentAnswers.answer.id":24,"experimentAnswers.answer.text":"NADPH with no precipitant","experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":22},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14673,"experimentAnswers.text":null,"experimentAnswers.answerId":24,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":22,"experimentAnswers.question.id":22,"experimentAnswers.question.text":"Precipitant pre-incubation condition","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":1,"experimentAnswers.question.type":null,"experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":24,"experimentAnswers.question.answers.text":"NADPH with no precipitant","experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":22,"experimentAnswers.answer.id":24,"experimentAnswers.answer.text":"NADPH with no precipitant","experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":22},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14673,"experimentAnswers.text":null,"experimentAnswers.answerId":24,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":22,"experimentAnswers.question.id":22,"experimentAnswers.question.text":"Precipitant pre-incubation condition","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":1,"experimentAnswers.question.type":null,"experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":23,"experimentAnswers.question.answers.text":"NADPH with precipitant","experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":22,"experimentAnswers.answer.id":24,"experimentAnswers.answer.text":"NADPH with no precipitant","experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":22},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14674,"experimentAnswers.text":null,"experimentAnswers.answerId":14,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":10,"experimentAnswers.question.id":10,"experimentAnswers.question.text":"Time linearity","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":1,"experimentAnswers.question.type":null,"experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":15,"experimentAnswers.question.answers.text":"Not available","experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":10,"experimentAnswers.answer.id":14,"experimentAnswers.answer.text":"Available","experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":10},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14674,"experimentAnswers.text":null,"experimentAnswers.answerId":14,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":10,"experimentAnswers.question.id":10,"experimentAnswers.question.text":"Time linearity","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":1,"experimentAnswers.question.type":null,"experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":14,"experimentAnswers.question.answers.text":"Available","experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":10,"experimentAnswers.answer.id":14,"experimentAnswers.answer.text":"Available","experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":10},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14675,"experimentAnswers.text":null,"experimentAnswers.answerId":12,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":9,"experimentAnswers.question.id":9,"experimentAnswers.question.text":"Protein linearity","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":1,"experimentAnswers.question.type":null,"experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":13,"experimentAnswers.question.answers.text":"Not available","experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":9,"experimentAnswers.answer.id":12,"experimentAnswers.answer.text":"Available","experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":9},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14675,"experimentAnswers.text":null,"experimentAnswers.answerId":12,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":9,"experimentAnswers.question.id":9,"experimentAnswers.question.text":"Protein linearity","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":1,"experimentAnswers.question.type":null,"experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":12,"experimentAnswers.question.answers.text":"Available","experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":9,"experimentAnswers.answer.id":12,"experimentAnswers.answer.text":"Available","experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":9},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14676,"experimentAnswers.text":null,"experimentAnswers.answerId":6,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":7,"experimentAnswers.question.id":7,"experimentAnswers.question.text":"Co-factors","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":100,"experimentAnswers.question.type":null,"experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":8,"experimentAnswers.question.answers.text":"P450 reductase","experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":7,"experimentAnswers.answer.id":6,"experimentAnswers.answer.text":"NADPH","experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":7},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14676,"experimentAnswers.text":null,"experimentAnswers.answerId":6,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":7,"experimentAnswers.question.id":7,"experimentAnswers.question.text":"Co-factors","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":100,"experimentAnswers.question.type":null,"experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":7,"experimentAnswers.question.answers.text":"NADPH regenerating system","experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":7,"experimentAnswers.answer.id":6,"experimentAnswers.answer.text":"NADPH","experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":7},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14676,"experimentAnswers.text":null,"experimentAnswers.answerId":6,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":7,"experimentAnswers.question.id":7,"experimentAnswers.question.text":"Co-factors","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":100,"experimentAnswers.question.type":null,"experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":6,"experimentAnswers.question.answers.text":"NADPH","experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":7,"experimentAnswers.answer.id":6,"experimentAnswers.answer.text":"NADPH","experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":7},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14676,"experimentAnswers.text":null,"experimentAnswers.answerId":6,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":7,"experimentAnswers.question.id":7,"experimentAnswers.question.text":"Co-factors","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":100,"experimentAnswers.question.type":null,"experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":5,"experimentAnswers.question.answers.text":"NADH","experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":7,"experimentAnswers.answer.id":6,"experimentAnswers.answer.text":"NADPH","experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":7},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14676,"experimentAnswers.text":null,"experimentAnswers.answerId":6,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":7,"experimentAnswers.question.id":7,"experimentAnswers.question.text":"Co-factors","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":100,"experimentAnswers.question.type":null,"experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":4,"experimentAnswers.question.answers.text":"NAD","experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":7,"experimentAnswers.answer.id":6,"experimentAnswers.answer.text":"NADPH","experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":7},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14676,"experimentAnswers.text":null,"experimentAnswers.answerId":6,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":7,"experimentAnswers.question.id":7,"experimentAnswers.question.text":"Co-factors","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":100,"experimentAnswers.question.type":null,"experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":3,"experimentAnswers.question.answers.text":"MgCl2","experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":7,"experimentAnswers.answer.id":6,"experimentAnswers.answer.text":"NADPH","experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":7},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14677,"experimentAnswers.text":null,"experimentAnswers.answerId":1,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":3,"experimentAnswers.question.id":3,"experimentAnswers.question.text":"Test system preparation","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":1,"experimentAnswers.question.type":null,"experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":2,"experimentAnswers.question.answers.text":"In-house preparation","experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":3,"experimentAnswers.answer.id":1,"experimentAnswers.answer.text":"Commercially available","experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":3},{"id":699,"uid":"NPDI--jKvig","name":"IC50 shift determination for mitragynine towards CYP2D6 activity in HLM without NADPH","overallEffect":1,"isControlData":false,"isIc50Shift":true,"croCutoff":"IC50<10 µM for reversible inhibition and IC50shift ≥1.5 fold for time dependent inhibition
","croIdentifier":null,"comment":null,"experimentalConditionsComment":"A cocktail of probe substrates for CYP2C9 (diclofenac), CYP2D6 (dextromethorphan), and CYP3A (midazolam) was used for the IC50shift determination.
Methanol (0.8 % v/v) served as solvent control. Tienilic acid (0.4 and 0.8 µM), paroxetine (0.25 and 0.5 µM), and 6',7'-dihydroxybergamottin (1 and 2 µM) served as positive control inhibitors of CYP2C9, CYP2D6, and CYP3A activities, respectively.","resultsComment":null,"internalComment":null,"objectCompoundId":12,"objectMetaboliteCompoundId":13,"precipitantCompoundId":94,"cytochromeB5Id":null,"studyId":143,"experimentTypeId":1,"testSystemId":6,"ic50ShiftExperimentId":698,"controlDataExperimentId":null,"controlDataForExperimentId":null,"naturalProductSampleId":null,"experimentType.id":1,"experimentType.name":"In Vitro Enzyme Inhibition","experimentType.isInVitro":true,"experimentType.isTransporter":false,"experimentType.isEnzyme":true,"experimentType.purl":"http://purl.obolibrary.org/obo/DIDEO_00000058","objectCompound.id":12,"objectCompound.name":"dextromethorphan","objectCompound.unii":"7355X3ROTS","objectCompound.inChIKey":"MKXZASYAUGDDCJ-NJAFHUGGSA-N","objectCompound.publicDescription":null,"objectCompound.internalComment":null,"objectCompound.conceptId":1119510,"objectCompound.enantiomerOfId":null,"objectCompound.concept.conceptId":1119510,"objectCompound.concept.conceptName":"Dextromethorphan","objectCompound.concept.domainId":"Drug","objectCompound.concept.vocabularyId":"RxNorm","objectCompound.concept.conceptClassId":"Ingredient","objectCompound.concept.standardConcept":"S","objectCompound.concept.conceptCode":"3289","objectCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectCompound.concept.invalid_reason":null,"precipitantCompound.id":94,"precipitantCompound.name":"mitragynine","precipitantCompound.unii":null,"precipitantCompound.inChIKey":"LELBFTMXCIIKKX-QVRQZEMUSA-N","precipitantCompound.publicDescription":null,"precipitantCompound.internalComment":null,"precipitantCompound.conceptId":null,"precipitantCompound.enantiomerOfId":null,"precipitantCompound.concept.conceptId":null,"precipitantCompound.concept.conceptName":null,"precipitantCompound.concept.domainId":null,"precipitantCompound.concept.vocabularyId":null,"precipitantCompound.concept.conceptClassId":null,"precipitantCompound.concept.standardConcept":null,"precipitantCompound.concept.conceptCode":null,"precipitantCompound.concept.validStartDate":null,"precipitantCompound.concept.validEndDate":null,"precipitantCompound.concept.invalid_reason":null,"objectMetaboliteCompound.id":13,"objectMetaboliteCompound.name":"dextrorphan","objectMetaboliteCompound.unii":null,"objectMetaboliteCompound.inChIKey":"JAQUASYNZVUNQP-PVAVHDDUSA-N","objectMetaboliteCompound.publicDescription":null,"objectMetaboliteCompound.internalComment":null,"objectMetaboliteCompound.conceptId":4349487,"objectMetaboliteCompound.enantiomerOfId":null,"objectMetaboliteCompound.concept.conceptId":4349487,"objectMetaboliteCompound.concept.conceptName":"Dextrorphan","objectMetaboliteCompound.concept.domainId":"Drug","objectMetaboliteCompound.concept.vocabularyId":"NDFRT","objectMetaboliteCompound.concept.conceptClassId":"Chemical Structure","objectMetaboliteCompound.concept.standardConcept":"C","objectMetaboliteCompound.concept.conceptCode":"N0000167299","objectMetaboliteCompound.concept.validStartDate":"1970-01-01T00:00:00.000Z","objectMetaboliteCompound.concept.validEndDate":"2099-12-31T00:00:00.000Z","objectMetaboliteCompound.concept.invalid_reason":null,"enzymes.id":10,"enzymes.name":"CYP2D6","enzymes.conceptId":4173631,"enzymes.experiment_enzyme_xref.enzymeId":10,"enzymes.experiment_enzyme_xref.experimentId":699,"transporters.id":null,"transporters.name":null,"transporters.conceptId":null,"transporters.experiment_transporter_xref.experimentId":null,"transporters.experiment_transporter_xref.transporterId":null,"quantifiedMetabolites.id":null,"quantifiedMetabolites.name":null,"quantifiedMetabolites.unii":null,"quantifiedMetabolites.inChIKey":null,"quantifiedMetabolites.publicDescription":null,"quantifiedMetabolites.internalComment":null,"quantifiedMetabolites.conceptId":null,"quantifiedMetabolites.enantiomerOfId":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.com":null,"quantifiedMetabolites.experiment_quantified_metabolite_xref.exp":null,"study.id":143,"study.uid":"NPDI-d8OUzg","study.name":"Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations","study.napdiIdentifier":null,"study.overallSummary":"\r\n- All kratom extracts inhibited CYP2C9, CYP2D6 and CYP3A (hepatic and intestinal) activities by similar extents, indicating minimal product to product variability with respect to CYP inhibition. Mitragynine inhibited CYP2C9, CYP2D6, and CYP3A activity by greater than 50%, warranting further investigation as a reversible or a time dependent inhibitor of the CYP activities.
\r\n- The 7-fold shift observed with mitragynine against intestinal and hepatic CYP3A activity suggests mitragynine is a time dependent inhibitor. IC50values were within the concentration range reported in post-mortem human plasma and tissues. Although no leftward shift was observed for CYP2D6, the IC50was also within the concentration range reported in post-mortem human plasma and tissues.
\r\n- Mitragynine was shown to be a strong competitive inhibitor of CYP2D6 activity. The robust Ki(~1 µM) will be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n- Mitragynine is a time dependent inhibitor of both intestinal and hepatic CYP3A activity. The efficiency of inactivation (kinact/KI) was similar to that of the clinically relevant time dependent inhibitor verapamil. The kinetic parameters, KIand kinactwill be applied to mechanistic and PBPK models to predict drug interaction potential.
\r\n
","study.pubmedId":33093187,"study.embaseId":null,"study.croIdentifier":"Washington State University","study.croInformation":"Washington State University","study.dateStart":null,"study.dateEnd":null,"study.internalComment":"Data entered by CB and review by RB.","study.status":"published","study.compoundId":null,"study.naturalProductUid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProductSampleId":"NPS-oDLatA","study.studySourceTypeId":1,"study.naturalProduct.uid":"NP-00ed1235-cbd8-4117-85df-298b8b3cdcad","study.naturalProduct.binomial":"Mitragyna speciosa","study.naturalProduct.name":"Kratom","study.naturalProduct.itis":null,"study.naturalProduct.srs":"d469b67d-e9a6-459f-b209-c59451936336","study.naturalProduct.source_id":"","study.naturalProduct.conceptId":null,"study.naturalProduct.concept.conceptId":null,"study.naturalProduct.concept.conceptName":null,"study.naturalProduct.concept.domainId":null,"study.naturalProduct.concept.vocabularyId":null,"study.naturalProduct.concept.conceptClassId":null,"study.naturalProduct.concept.standardConcept":null,"study.naturalProduct.concept.conceptCode":null,"study.naturalProduct.concept.validStartDate":null,"study.naturalProduct.concept.validEndDate":null,"study.naturalProduct.concept.invalid_reason":null,"study.compound.id":null,"study.compound.name":null,"study.compound.unii":null,"study.compound.inChIKey":null,"study.compound.publicDescription":null,"study.compound.internalComment":null,"study.compound.conceptId":null,"study.compound.enantiomerOfId":null,"study.studySourceType.id":1,"study.studySourceType.name":"Published report","testSystem.id":6,"testSystem.name":"Pooled human liver microsomes","testSystem.sortOrder":0,"testSystem.conceptId":-7999662,"testSystem.categoryId":2,"testSystem.category.id":2,"testSystem.category.name":"Cell fraction","testSystem.category.sortOrder":2,"testSystem.category.requiresCytochromeB5":false,"cytochromeB5.id":null,"cytochromeB5.name":null,"cytochromeB5.sortOrder":null,"cytochromeB5.conceptId":null,"controlDataExperiment.id":null,"controlDataExperiment.uid":null,"controlDataExperiment.name":null,"controlDataExperiment.overallEffect":null,"controlDataExperiment.isControlData":null,"controlDataExperiment.isIc50Shift":null,"controlDataExperiment.croCutoff":null,"controlDataExperiment.croIdentifier":null,"controlDataExperiment.comment":null,"controlDataExperiment.experimentalConditionsComment":null,"controlDataExperiment.resultsComment":null,"controlDataExperiment.internalComment":null,"controlDataExperiment.objectCompoundId":null,"controlDataExperiment.objectMetaboliteCompoundId":null,"controlDataExperiment.precipitantCompoundId":null,"controlDataExperiment.cytochromeB5Id":null,"controlDataExperiment.studyId":null,"controlDataExperiment.experimentTypeId":null,"controlDataExperiment.testSystemId":null,"controlDataExperiment.ic50ShiftExperimentId":null,"controlDataExperiment.controlDataExperimentId":null,"controlDataExperiment.controlDataForExperimentId":null,"controlDataExperiment.naturalProductSampleId":null,"controlDataExperiment.experimentType.id":null,"controlDataExperiment.experimentType.name":null,"controlDataExperiment.experimentType.isInVitro":null,"controlDataExperiment.experimentType.isTransporter":null,"controlDataExperiment.experimentType.isEnzyme":null,"controlDataExperiment.experimentType.purl":null,"controlDataExperiment.objectCompound.id":null,"controlDataExperiment.objectCompound.name":null,"controlDataExperiment.objectCompound.unii":null,"controlDataExperiment.objectCompound.inChIKey":null,"controlDataExperiment.objectCompound.publicDescription":null,"controlDataExperiment.objectCompound.internalComment":null,"controlDataExperiment.objectCompound.conceptId":null,"controlDataExperiment.objectCompound.enantiomerOfId":null,"controlDataExperiment.precipitantCompound.id":null,"controlDataExperiment.precipitantCompound.name":null,"controlDataExperiment.precipitantCompound.unii":null,"controlDataExperiment.precipitantCompound.inChIKey":null,"controlDataExperiment.precipitantCompound.publicDescription":null,"controlDataExperiment.precipitantCompound.internalComment":null,"controlDataExperiment.precipitantCompound.conceptId":null,"controlDataExperiment.precipitantCompound.enantiomerOfId":null,"controlDataExperiment.objectMetaboliteCompound.id":null,"controlDataExperiment.objectMetaboliteCompound.name":null,"controlDataExperiment.objectMetaboliteCompound.unii":null,"controlDataExperiment.objectMetaboliteCompound.inChIKey":null,"controlDataExperiment.objectMetaboliteCompound.publicDescriptio":null,"controlDataExperiment.objectMetaboliteCompound.internalComment":null,"controlDataExperiment.objectMetaboliteCompound.conceptId":null,"controlDataExperiment.objectMetaboliteCompound.enantiomerOfId":null,"controlDataExperiment.enzymes.id":null,"controlDataExperiment.enzymes.name":null,"controlDataExperiment.enzymes.conceptId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.enzymeId":null,"controlDataExperiment.enzymes.experiment_enzyme_xref.experiment":null,"controlDataExperiment.transporters.id":null,"controlDataExperiment.transporters.name":null,"controlDataExperiment.transporters.conceptId":null,"controlDataExperiment.transporters.experiment_transporter_xref.":null,"controlDataExperiment.quantifiedMetabolites.id":null,"controlDataExperiment.quantifiedMetabolites.name":null,"controlDataExperiment.quantifiedMetabolites.unii":null,"controlDataExperiment.quantifiedMetabolites.inChIKey":null,"controlDataExperiment.quantifiedMetabolites.publicDescription":null,"controlDataExperiment.quantifiedMetabolites.internalComment":null,"controlDataExperiment.quantifiedMetabolites.conceptId":null,"controlDataExperiment.quantifiedMetabolites.enantiomerOfId":null,"controlDataExperiment.quantifiedMetabolites.experiment_quantifi":null,"experimentAnswers.id":14677,"experimentAnswers.text":null,"experimentAnswers.answerId":1,"experimentAnswers.experimentId":699,"experimentAnswers.questionId":3,"experimentAnswers.question.id":3,"experimentAnswers.question.text":"Test system preparation","experimentAnswers.question.required":false,"experimentAnswers.question.maxAnswers":1,"experimentAnswers.question.type":null,"experimentAnswers.question.conceptId":null,"experimentAnswers.question.answers.id":1,"experimentAnswers.question.answers.text":"Commercially available","experimentAnswers.question.answers.sortOrder":null,"experimentAnswers.question.answers.conceptId":null,"experimentAnswers.question.answers.questionId":3,"experimentAnswers.answer.id":1,"experimentAnswers.answer.text":"Commercially available","experimentAnswers.answer.sortOrder":null,"experimentAnswers.answer.conceptId":null,"experimentAnswers.answer.questionId":3}]